|
Healthy Aging and Memory Study Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Healthy Aging and Memory Study conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Healthy Aging and Memory Study Clinical research trials and Healthy Aging and Memory Study healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Healthy Aging and Memory Study. Healthy Aging and Memory Study Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Healthy Aging and Memory Study clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Healthy Aging and Memory Study condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "H" Clinical Trials Conditions > Healthy Aging and Memory Study  Healthy Aging and Memory Study
Healthy Aging and Memory Study
For Condition: Alzheimer Disease
Status: No longer recruiting
Sponsor(s): National Institute on Aging (NIA) ,
Synopsis: This project will focus on the development and testing of efficient, cost effective measures that are specifically designed for use in Alzheimer's Disease (AD) primary prevention trials.
Details: This project will focus on the development and testing of efficient, cost effective measures that are specifically designed for use in AD primary prevention trials. The new or improved measures that have been developed will then be evaluated in 650 nondemented subjects enrolled in a simulated Alzheimer's disease prevention trial. Once enrolled, subjects will be followed for four years with annual clinical evaluations and interim six-month phone calls.
Eligibility:
Study Type: Observational, Screening, Longitudinal, Defined Population, Prospective Study
Minimum Age/Maximum Age: 75 Years/
Genders: Both
Protocol Entry Criteria: - 75 years or older. - Fluent in English or Spanish. - Stable medical condition for four weeks prior to screening visit. - Stable medications for four weeks prior to screening visit. - Either cognitively normal, or mild cognitive impairment. If MCI, the subject's CDR at screening have a global score of 0.5. - mMMSE score greater than 88 for subjects with at least 8 years education, or greater than 80 for subjects with less than 8 years education, and FCSRT total free plus cued recall score greater than 44 with 3 learning trials. - Willing to participate in four to five year follow-up study. - Willing to identify person who can serve as informant. - At least six years education or work history sufficient to exclude mental retardation
Total Enrollment: 650
Location and Contact Information:
Overall Study Official:
StevenFerris, Study Director, New York University School of Medicine
Stanford/Va Aging Clinical Research Center
Palo Alto, California, 94304
United States
Baumel-Eisner Neuromedical Institute, Miami Beach
Miami, Florida, 33154
United States
University of California, Davis
Sacramento, California, 95817
United States
Medical University of South Carolina
North Charleston, South Carolina, 29406
United States
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007
United States
University of California, Los Angeles
Los Angeles, California, 90095-1769
United States
Emory University
Atlanta, Georgia, 30329
United States
Northwestern University
Chicago, Illinois, 60611
United States
Columbia University
New York City, New York, 10032
United States
Washington University
St. Louis, Missouri, 63108
United States
University of Nevada, Las Vegas
Las Vegas, Nevada, 89102
United States
Indiana University Alzheimer's Center
Indianapolis, Indiana, 46202
United States
New York University School of Medicine
New York City, New York, 10016
United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213
United States
Baumel-Eisner Ft Lauderdale
Ft. Lauderdale, Florida, 33321
United States
Michigan Alzheimer's Disease Research Center
Ann Arbor, Michigan, 48109-2007
United States
Mt. Sinai Medical Center
New York City, New York, 10029
United States
Oregon Health Sciences University
Portland, Oregon, 97201
United States
Sun Health Research Institute
Sun City, Arizona, 85351
United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115
United States
University of Alabama, Birmingham
Birmingham, Alabama, 35294-1150
United States
Rush Alzheimer's Disease Center
Chicago, Illinois, 60612
United States
Baumel-Eisner Neuromedical Institute, Boca Raton
Boca Raton, Florida, 33486
United States
Boston University School of Medicine
Boston, Massachusetts, 02118
United States
University of South Florida, Tampa
Tampa, Florida, 33617
United States
University of Rochester
Rochester, New York, 14620
United States
University Hospitals of Cleveland
Cleveland, Ohio, 44120-1013
United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States
Memorial Hospital of Rhode Island (Brown University)
Pawtucket, Rhode Island, 02860
United States
Mayo Clinic, Jacksonville
Jacksonville, Florida, 32224
United States
Johns Hopkins University
Baltimore, Maryland, 21287-7218
United States
University of California, San Diego
La Jolla, California, 92037
United States
Yale University School of Medicine
New Haven, Connecticut, 06510
United States
University of Texas Southwestern Medical Center
Dallas, Texas, 75390-9070
United States
University of Kentucky, Lexington
Lexington, Kentucky, 40506
United States
Mayo Alzheimer's Disease Center
Rochester, Minnesota, 55901
United States
University of Southern California
Los Angeles, California, 90033-1039
United States
Wien Center for Memory Disorders
Miami, Florida, 33140
United States
University of California, Irvine
Irvine, California, 92697-4285
United States
Additional Information:
Study ID Numbers: IA0032;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00034567
Other Alzheimer Disease Studies:
1. Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
2. Gene Therapy for Alzheimer's Disease Clinical Trial
3. Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
4. Agitation in Alzheimer's Disease
5. Treating Behavioral Disturbances in Individuals with Dementia
Related Studies:
Other Alzheimer Disease Clinical Trials
Other Illinois Clinical Trials
Other Chicago Clinical Trials
Healthy Aging and Memory Study
|
|
|
|
|
|
|
|
